T46.0 - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
The ICD 10 Code for
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action is listed as
T46.0. Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
ICD 10 CM Field |
Value |
Diagnosis Code: |
T46.0
|
Description: |
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action |
|
Chapter |
Injury, poisoning and certain other consequences of external causes (S00-T88) |
Block |
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) |
Parent |
T46 - Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system |
ICD-10-CM Children (deeper level / typically more specific) of T46.0: |
T46.0X - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action |
ICD-10-CM Siblings (same level / similar specificity) of T46.0: |
T46.1 - Poisoning by, adverse effect of and underdosing of calcium-channel blockers |
T46.2 - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified |
T46.3 - Poisoning by, adverse effect of and underdosing of coronary vasodilators |
T46.4 - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors |
T46.5 - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs |
T46.6 - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
T46.7 - Poisoning by, adverse effect of and underdosing of peripheral vasodilators |
T46.8 - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents |
T46.9 - Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system |